Overview

Morphine, Dyspnea, Exercise and COPD

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The investigators are studying the effect of a single dose Opioid drug (Morphine) on dyspnea and exercise tolerance in COPD patients.
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center
McGill University Health Centre/Research Institute of the McGill University Health Centre
Treatments:
Morphine